Edition:
India

Biogaia AB (BIOGb.ST)

BIOGb.ST on Stockholm Stock Exchange

461.50SEK
15 Aug 2018
Change (% chg)

-2.50kr (-0.54%)
Prev Close
464.00kr
Open
463.00kr
Day's High
464.50kr
Day's Low
460.00kr
Volume
16,794
Avg. Vol
22,715
52-wk High
464.50kr
52-wk Low
278.50kr

Chart for

About

Biogaia AB is a Sweden-based company engaged in the development and sell of probiotic products, primarily based on the Lactobacillus reuteri bacteria. The Company’s activities are divided into three segments: Finished consumer products, which distributes tablets, drops, Oral Rehydration Solutions (ORSs), and oral health... (more)

Overall

Beta: 0.84
Market Cap(Mil.): kr4,987.04
Shares Outstanding(Mil.): 16.60
Dividend: 3.16
Yield (%): 2.50

Financials

  BIOGb.ST Industry Sector
P/E (TTM): 30.27 22.52 40.76
EPS (TTM): 9.93 -- --
ROI: 48.48 12.26 62.30
ROE: 48.53 15.63 73.91

BRIEF-Biogaia Q1 operating profit roughly unchanged yr/yr

* BIOGAIA AB Q1 OPERATING PROFIT AMOUNTED TO SEK 56.2 MILLION (56.1) Source text for Eikon: Further company coverage: (Reporting by Stockholm Newsroom)

25 Apr 2018

BRIEF-Biogaia increases stake in MetaboGen to 62 pct

* Has decided to acquire additional shares in the associated company MetaboGen AB and is now investing SEK 11.7 million in shares in the company.

06 Apr 2018

BRIEF-Biogaia partners with Dr Reddy's for India launch of protectis drops

* BIOGAIA HAS ENTERED INTO A PARTNERSHIP WITH DR. REDDY’S LABORATORIES FOR THE MARKETING AND DISTRIBUTION OF BIOGAIA PROTECTIS DROPS IN THE INDIAN MARKET

23 Mar 2018

Earnings vs. Estimates